# Cui Zhiping

> Cui Zhiping is a seed investor at Fosun Pharma backing Health Care and Medical. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Fosun Pharma](https://shizune.co/investors/profile/fosun-pharmaceutical)
- Total investments: 3
- Last investment: Jan 2026
- Lead investor: 67%
- Last updated: Aug 2026

Cui Zhiping is a seed investor at Fosun Pharma focused on Health Care and Medical. Cui Zhiping is Vice President and General Manager of VC Investment Department of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.. He was born in April 1963 and holds a master’s degree. From 2001 to 2005, he served for Shanghai Pharmaceutical Co., Ltd.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Medical | 1 | 33% |
| Therapeutics | 1 | 33% |
| Medical Device | 1 | 33% |
| Pharmaceutical | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Xingaotopi | Xingaotopi focuses on the innovative development of novel therapeutic drugs for sensorineural hearing loss, aiming to restore auditory function and improve quality of life through advanced biomedical research and cutting-edge treatment technologies. | $14.3M | Seed | Jan 04, 2026 |  |
| Conjustar | Conjustar, a protein-conjugated medicine developer that has rapidly built a robust R&D pipeline through a combination of introduction and independent research and development. it delivers more effective and safer new cancer therapy options to the majority of cancer patients. | $13.6M | Seed | Jan 16, 2025 |  |
| Conjustar | Conjustar, a protein-conjugated medicine developer that has rapidly built a robust R&D pipeline through a combination of introduction and independent research and development. it delivers more effective and safer new cancer therapy options to the majority of cancer patients. | $12.7M | Seed | Jan 30, 2024 |  |

3 of 3 investments shown.

## Co-investors
- [Shenzhen Qianhai Liyuan](https://shizune.co/investors/profile/shenzhen-qianhai-liyuan) — VC Fund, 2 deals together
- [Dingxin Capital](https://shizune.co/investors/profile/dingxin-capital) — VC Fund, 1 deal together
- [Gree Electric Appliance](https://shizune.co/investors/profile/gree-electric-appliance) — VC Fund, 1 deal together
- [Hengqin Venture Capital](https://shizune.co/investors/profile/hengqin-venture-capital) — VC Fund, 1 deal together
- [Nanjing Innovation Capital Group](https://shizune.co/investors/profile/nanjing-innovation-capital-group) — VC Fund, 1 deal together
- [Nanjing Xingang High Investment](https://shizune.co/investors/profile/nanjing-xingang-high-investment) — VC Fund, 1 deal together

## About Fosun Pharma

VC Fund · Shanghai, China

Fosun Pharma is a biopharmaceutical and healthcare industry. Fosun Pharma has captured opportunities within the rapidly developing Chinese healthcare industry as well as from the globalization of Chinese healthcare companies in general. Fosun Pharma's operations strategically cover several important segments of the healthcare industryvalue-chain, including: pharmaceutical manufacturing, distribution and retail.

5 contacts available at Fosun Pharma.

| Name | Title | Profile |
| --- | --- | --- |
| Cui Zhiping | Vice President and General Manager of VC Investment Department | https://shizune.co/investors/profile/cui-zhiping |
| Hongfei Jia | SVP, Joint Chief Investment Officer and General Manager of International Operations Department | https://shizune.co/investors/profile/hongfei-jia |
| Wai Danny | Independent Non-Executive Director | https://shizune.co/investors/profile/wai-danny |
| Wu Yifang | Senior vice president and Chief operating officer | https://shizune.co/investors/profile/wu-yifang |
| Zhou Biao | SVP, General Manager of Legal Department and General Manager of Independent Inspectors Department | https://shizune.co/investors/profile/zhou-biao |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Cui Zhiping invest in?

Cui Zhiping invests primarily in Health Care, Medical and Therapeutics startups, most often at Seed stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Cui Zhiping last invest?

The most recent investment recorded for Cui Zhiping closed in Jan 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co